-
-
-
-
-
As PI of this study: *
-
-
-
3. Was this event previously reported to the IRB? *
-
-
5. In light of this potential adverse event, should the consent form be revised? *
-
-
6. In light of this potential adverse event, should any part of the study/project plan or methodology be revised? *
-
-
7. Should currently enrolled subjects be re-consented? *
-
-
An IRB member will contact you to discuss this report. I understand this is a legal representation of my signature.
Clear
-